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Abstract: Introduction: Previous studies have raised the probably of cardiac manifestation in tramadol poisoning. How-
ever, conclusive information on electrocardiographic (ECG) abnormalities of tramadol overdose remains to be
explained. Therefore, the present study aimed to evaluate the epidemiology of ECG abnormalities in tramadol
poisoned patients. Methods: In a prospective cross-sectional study, all patients with tramadol poisoning, who
were admitted to the emergency department of Loghman Hospital during 2012 - 2013, were evaluated. Patients
baseline characteristics and ECG findings including axis, rate, rhythm, PR interval, QRS duration, QTc interval,
evidence of Brugada pattern, and evidence of blocks were recorded. Obtained Data were descriptively analyzed
using SPSS 21.0 statistical software. Results: 1402 patients with the mean age of 24 ± 6 years were studied (71.1%
male). Sinus tachycardia was detected in 463 (33%) patients, sinus bradycardia in one patient (0.07%), right axis
deviation in 340 (24.2), QRS widening in 91 (6.5%), long QTc interval in 259 (18.4%), dominant S wave in either I
or aVL lead in 395 (28.1%), and right bundle branch block in 73 (5.2%). Increased PR interval was not detected
in any cases. The evidence of Brugada pattern was observed in 2 (0.14%) patients (100% male), both symptoma-
tized with seizure. All abnormalities had same sex distribution. Conclusion: Based on the results of the present
study, the most common types of ECG changes were sinus tachycardia, a deep S wave in leads I and aVL, right
axis deviation, and long QTc interval, respectively. Brugada pattern and sinus bradycardia were rarely presented.
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1. Introduction
T
ramadol is a synthetic centrally acting analgesic agent
with opioid and non-opioid properties. Due to its rel-
atively lower risk of respiratory depression or physi-
cal dependence and better safety profile in comparison with
other opiates, it is extensively used for mild to moderate pain
relief (1). The main adverse reactions of tramadol are nausea,
dizziness, anorexia, and most importantly seizures and hy-
potension, which may occur in therapeutic or toxic doses (2).
The drug is available, in both parenteral and oral pharmaceu-
tical dosage forms; and has become one of the most widely
dispensed analgesics in Iran’s essential drugs list since 2003.
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In recent years, tramadol abuse, misuse, and overdose have
been dramatically increasing in Iran. Even international poi-
soning reports and suicide commitments by tramadol abuse
have been increasing (3-5). Triad of opiate poisoning in-
cluding miosis, respiratory depression, and decreased level
of consciousness can be seen in tramadol overdose too, but
unlike opioids, it leads to irritability, increased deep tendon
reflexes, tremor, and hypertension. Other symptoms include
urinary retention, rhabdomyolysis, seizures, and pulmonary
edema (6, 7). As with many other drug toxicities, cardiac
manifestations are also expected in tramadol poisoning. The
cardiac symptoms may range from innocuous electrocardio-
graphic (ECG) manifestations, such as sinus tachycardia, to
life-threatening complications. It seems that tramadol over-
dose leads to some changes in the ECG through blocking
of fast sodium and potassium channels (8). The study of
ECG abnormality in 479 tramadol poisoned patients showed
30.6% sinus tachycardia, 24.6% QTC prolongation, and 31.7%
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QRS widening (9). There is a lack of information regarding
possible effects of tramadol poisoning on the cardiovascular
system and the most prevalent cardiac side effects of drug.
Therefore, the present study was aimed to evaluate the epi-
demiology of ECG changes following tramadol poisoning in
Iranian population.
2. Methods
2.1. Study design and setting
The present prospective cross-sectional study included tra-
madol poisoned patients who were admitted to emergency
department (ED) of Loghman Hakim Hospital, Tehran, Iran,
during one year from 2012 to 2013, using census sampling.
The patients with co-ingestion, history of heart disease, his-
tory of dysrhythmias, as well as chronic tramadol users were
excluded. A questionnaire consisting of demographic data
(age, sex), vital signs (blood pressure, heart rate, respiratory
rate, level of consciousness), time to ED arrival, dose of inges-
tion, history of previous use, drug history, comorbid diseases,
cause of ingestion, and ECG findings (Axis, rate, rhythm, PR
interval, QRS duration, QTc interval, evidence of Brugada
pattern and blocks) were filled for all participants. ECGs were
performed after physical examination by an emergency spe-
cialist. The protocol of the study was confirmed by Ethi-
cal Committee of Shahid Beheshti University of Medical Sci-
ences. All authors adhered to Helsinki recommendations
and confidentiality of patients data. All costs related to the
project were incured by researchers, and no cost was im-
posed on patients. In addition, no changes were made in pa-
tients’ diagnosis and treatment process.
2.2. Terms and definitions
ECG abnormalities were defined as: sinus tachycardia (heart
rate > 100 beats per minute), sinus bradycardia (heart rate
< 60 beats per minute), increased PR interval (PR > 200 mil-
liseconds), widening of the QRS duration (QRS ≥ 120 mil-
liseconds), heart axis deviation (axis deviation in the frontal
plane > 40 degree), R wave more than 1 millimeter in lead
of aVL, and long corrected QT interval (QTc > 440 millimeter
/second). Brugada pattern was defined as positive end of the
QRS and ST-segment elevation in right precordial leads (V1
to V3).
2.3. Statistical analysis
Data were descriptively analyzed using SPSS version 21 sta-
tistical software. Qualitative data were reported as frequency
and percentage, and quantitative ones as mean ± standard
deviation.
Table 1: Baseline characteristics of the studied patients
Variables Number (%)
Age (years)
14 - 25 925 (66%)
26 - 35 393 (28 %)





Mean ± SD 94 ± 12.94
Blood pressure (mmHg)
< 90 191 (13.6%)
> 90 1211 (86.4%)
Respiratory rate / minute
< 20 1052 (75%)
> 20 350 (25%)
Level of Consciousness (GCS)
15 137 (9.8%)
< 15 1265 (90.2%)
Time to ED arrival mean ± SD(hour) 2 ± 0.5




GCS: Glasgow coma scale ; SD: standard deviation.
3. Results
In this prospective cross-sectional study, 1402 patients with
the mean age of 24 ± 6 years (14- 53) were studied (71.1%
male). The baseline characteristics of patients are summa-
rized in table 1. Sinus tachycardia was detected in 463 (33%)
patients, sinus bradycardia in one patient (0.07%), right axis
deviation in 340 (24.2), QRS widening in 91 (6.5%), long QTc
interval in 259 (18.4%), dominant S wave in either I or aVL
lead in 395 (28.1%), and right bundle branch block in 73
(5.2%) patients. Increased PR interval was not detected in
any of the cases. The evidences of Brugada pattern was ob-
served in 2 (0.14%) patients (100% male), both symptoma-
tized with seizure. Table 2 shows the frequency of ECG ab-
normalities based on sex distribution.
4. Discussion
Based on the results of the present study, the most common
types of ECG changes were sinus tachycardia (33%), a deep S
wave in leads I and aVL (28%), right axis deviation (24%) and
long QTc interval (18%), respectively. Brugada pattern and
sinus bradycardia were rarely presented. Most studies con-
cerning complications of tramadol overdose, have described
central nervous system (CNS) manifestations of the drug and
seizure (10-14). There have been only few reports on car-
diovascular toxicities including ECG abnormalities (15-17).
Emamhadi et al. first described ECG manifestations of tra-
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Table 2: Frequency of ECG abnormalities based on sex distribution
Abnormality Number (%)
Sinus tachycardia (HR > 100 / minute) 463 (33%)
Male 438 (94.6%)
Female 25 (5.4%)





Right axis deviation ( > 40 degree) 340 (24.3)
Male 259 (76.2%)
Female 81 (23.8%)
Dominant S wave (in I or aVL leads) 394 (28%)
Male 372 (94.2%)
Female 23 (5.8%)
Right bundle branch block 73 (5.2%)
Male 40 (54.8%)
Female 33 (45.2%)
madol overdose in a retrospective study. Our results are very
similar to those obtained by Emamhadi’s work on 479 pa-
tients poisoned by tramadol. Their findings demonstrated
occurrence of tachycardia in 30.6%, long QRS duration in
7.5%, QTc > 440 millimeter/second in 24.6%, R wave height
more than 1 mm in aVR lead in 22.1%, right axis deviation
in 31.7%, and complete or incomplete right bundle branch
block in 4.6% of patients. They concluded that tramadol
overdose, through fast blockade of sodium and potassium
channels, leads to some changes in the ECG, which poten-
tially may progress to life-threatening arrhythmias (9) Sinus
tachycardia was observed in a significant number of patients
(33%) the majority of which were male (94%). Although sinus
tachycardia is usually non-specific for opioids, and bradycar-
dia is a more common finding with other opioids (11, 18), our
findings are in line with some other studies focusing on tra-
madol. In a mult-icenter prospective case series study of pa-
tients with tramadol overdose, Spiller et al. observed tachy-
cardia in 13% of patients (12). Marquardt and colleagues
also reported 17.4% tachycardia (19). However, in compar-
ison with previously performed studies, the number of pa-
tients in the current study was vastly higher, although the
sex ratio was not very different from other studies. This is
largely because the incidence of drug poisoning in Iran is not
comparable to Western countries. Tramadol in Iran is more
easily and readily available compared to Western countries
(3). Brugada pattern was seen in only 2 patients, both were
male. In the study by Emamhadi et al. there was one patient
(among 479) with Brugada pattern (9). There was also one
isolated case report of Brugada pattern by Cole JB, which be-
lieved that sodium-channel blockade effect of tramadol was
responsible for this complication of the drug (15). Tramadol
has been previously shown to reversibly block sodium chan-
nels especially at high concentrations. However, it is unclear
that Brugada syndrome existed before tramadol poisoning or
is one of its complications (15, 20). QTc prolongation was
also a common ECG abnormality among our patients that
may also be attributed to rapid blockade of sodium chan-
nels. Yet, it may also be due to a probable potassium chan-
nel blockade since tramadol has been previously shown to
have inhibitory effects on potassium channels (21-23). QTc
prolongation is the primary ECG manifestation of potassium
channel blockers (8). QRS widening, seen in few patients,
was also reported by Emamhadi et al. in 7% of their patients.
In this study, like other studies, no relationship between the
ECG changes and amount of drug used or history of drug use
was observed. Finding the accurate pattern of ECG abnor-
mality (s) of tramadol poisoning needs further multi-center
studies with larger sample size. In addition, study on phar-
macologic characteristics of tramadol could be helpful in dis-
covering its mechanism of cardiac effect and ECG abnormal-
ities that follow.
5. Conclusion
Based on the results of the present study, the most common
types of ECG changes were sinus tachycardia, a deep S wave
in leads I and aVL, right axis deviation, and long QTc inter-
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